Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pfizer
Pfizer
Page 8 of 37
Health
FDA clears Pfizer boosters for 12-to-15 year-olds
By
Lauran Neergaard
and
The Associated Press
January 3, 2022
Finance
Omicron is upping booster jab demand. So why are COVID vaccine makers’ shares tanking?
By
Tech Reporter
December 29, 2021
Health
Moderna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries
By
Digital Assets Editor
December 27, 2021
Health
FDA authorizes Merck COVID pill a day after approving Pfizer’s
By
Matthew Perrone
and
The Associated Press
December 23, 2021
Health
Pfizer pill becomes first FDA-approved home COVID treatment
By
Matthew Perrone
and
The Associated Press
December 22, 2021
Health
Israel to give fourth COVID vaccine doses to combat Omicron, despite lack of data on second boosters
By
Editorial Team
December 22, 2021
Health
FDA set to authorize Pfizer and Merck COVID pills this week
By
Josh Wingrove
,
Jennifer Jacobs
,
Robert Langreth
and
Bloomberg
December 21, 2021
Health
EU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
By
Trading Desk
December 20, 2021
Health
Europe taps Pfizer and BioNTech to provide 180 million more vaccines to face ‘ferocious’ Omicron threat
By
Contributing Writer
December 17, 2021
Health
J&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
By
Editorial Team
December 17, 2021
Newsletters
Stocks and crypto falter, looking set to close out the week on a losing streak
By
Contributing Writer
December 17, 2021
Health
CDC panel recommends Pfizer and Moderna vaccines over Johnson & Johnson
By
Lauran Neergaard
,
Mike Stobbe
and
The Associated Press
December 16, 2021
Health
As COVID deaths top 800,000, Omicron and Delta variants threaten another U.S. surge
By
Erika Fry
and
Nicolas Rapp
December 15, 2021
Health
Germany’s new health minister delivers a bombshell: The country doesn’t have enough COVID-19 vaccines
By
Digital Assets Editor
December 15, 2021
Health
Pfizer pill reduces risk of COVID hospitalization and death by 89%, and should protect against Omicron
By
Crypto Correspondent
December 14, 2021
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Investment Desk
Politics
Trump's FAA punishes most of nation's air traffic workers by only giving $10,000 bonuses to the 776 with perfect...
By
Josh Funk
and
The Associated Press
Success
Shark Tank star Robert Herjavec says the best Gen Z career advice comes from Mark Cuban—it's that nobody cares if...
By
Research Team